Effects of the nature of adjuvant and site of parenteral immunization on the serum and mucosal immune responses induced by a nasal boost with a vaccine alone

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 5, 1998, Pages 732-736

  Guy, Bruno ^a   Fourage, Sophie ^a   Hessler, Catherine ^a   Sanchez, Violette ^a   Quentin Millet, Marie José ^a  

^a Research Department   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INFLUENZA VACCINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BINDING SITE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INFLUENZA VACCINATION; INJECTION SITE; INTRANASAL DRUG ADMINISTRATION; LYMPHATIC DRAINAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032422019     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.5.732-736.1998     Document Type: Article

References (18)

1. Barone, R. 1996. Anatomie comparée des mammifères domestiques, vol. 5. Angiologie. p. 667-864. Vigot, Paris, France.
2. Erdile, L., and B. Guy. 1997. OspA lipoprotein of Borrelia burdogferi is a mucosal immunogen and adjuvant. Vaccine 15:988-996.
3. Guy, B., C. Hessler, S. Fourage, P. Lecoindre, M. Chevalier, S. Peyrol, M. Boude, J. Haensler, B. Rokbi, and M. J. Quentin-Millet. 1998. Mucosal, systemic or combined therapeutic immunizations in cynomolgus monkeys naturally infected with Gastrospirillum hominis like organisms. Vaccine Res. 6:141-150.
4. Guy, B., C, Hessler, S. Fourage, J. Haensler, E. Vialon-Lafay, B. Rokbi, and M. J. Quentin Millet. 1998. Systemic immunization with urease protects mice against Helicobacter pylori infection. Vaccine 16:850-856.
5. Guy, B., C. Hessler, S. Fourage, B. Rokbi, and M.-J. Quentin-Millet. Comparison between targeted and untargeted systemic immunization with adjuvanted urease to cure H. pylori infection in mice. Vaccine, in press.
6. Kawabata, S., C. J. Miller, T. Lehner, K. Fujihashi, M. Kubota, J. McGhee, K. Imaoka, T. Hiroi, and H. Kyono. 1998. Induction of Th2 cytokine expression for p27-specific IgA B cell responses after targeted lymph node immunization with simian immunodeficiency virus antigens in Rhesus macaques. J. Infect. Dis. 177:26-33.
7. Kensil, C. R., U. Patel, M. Lennick, and D. Marciani. 1991. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J. Immunol. 146:431-439.
8. Keren, D. F., R. A. McDonald, and J. L. Carey. 1988. Combined parenteral and oral immunization results in an enhanced mucosal IgA response to Shigella flexneri. Infect. Immun. 56:910-915.
9. Kirkpatrick, C. E., T. J. Nolan, and J. P. Farrel. 1987. Rate of Leishmania-induced skin-lesion development in rodents depends on the site of inoculation. Parasitology 94:451-465.
10. Lehner, T., L. Bergmaier, L. Tao, C. Panagiotidi, L. S. Klavinskis, L. Hussain, R. G. Ward, N. Meyers, S. E. Adams, A. J. H. Gearing, and R. Brookes. 1994. Targeted lymph node immunization with SIV p27 antigen to elicit genital, rectal and urinary immune responses in nonhuman primates. J. Immunol. 153:1858-1868.
11. Lehner, T., Y. Wang, M. Cranage, L. A. Bergmaier, E. Mitchell, L. Tao, G. Hall, M. Dennis, N. Cook, R. Brookes, L. Klavinskins, I. Jones, C. Doyle, and R. Ward. 1996. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat. Med. 2:767-775.
12. McGhee, J. R., and H. Kiyono. 1992. Mucosal immunity to vaccines: current concepts for vaccine development and immune response analysis, p. 3-12. In J. E. Ciardi et al. (ed.). Genetically engineered vaccines. Plenum Press, New York, N.Y.
13. Mega, J., J. R. McGhee, and H. Kiyono. 1992. Cytokine and lg-producing cells in mucosal effector tissues: analysis of IL5 and IFNγ producing T cells. T cell receptor expression, and IgA plasma cells from mouse salivary gland associated tissues. J. Immunol. 148:2030-2038.
14. Moghimi, S. M., and A. R. Rabaji-Siahboomi. 1996. Advanced colloid-based systems for efficient delivery of drugs and diagnostic agents to the lymphatic tissues. Prog. Biophys. Mol. Biol. 65:221-249.
15. Nabors, G., and J. P. Farrel. 1994. Site-specific immunity to Leishmania major in SWR mice: the site of infection influences susceptibility and ex-pression of the antileishmanial immune response. Infect. Immun. 62:3655-3662.
16. Nabors, G., T. Nolan, W. Croop, J. Li, and J. P. Farrell. 1995. The influence of the site of parasite inoculation on the development of Th1 and Th2 type immune responses in (Balb/C X C57B1/6) F1 mice infected with Leishmania major. Parasite Immunol. 17:569-579.
17. Poulter, L. W., and C. R. Pandolph. 1982. Mechanisms of immunity to leishmaniasis. IV. Significance of lymphatic drainage from the site of infection. Clin. Exp. Immunol. 48:396-406.
18. Walker, R. L. 1994. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 12:387-400.